Cancer cells are pretty bold and clever—they hijack cellular survival and healing processes in order to fuel their growth, ...
A Nature paper describes an innovative analog in-memory computing (IMC) architecture tailored for the attention mechanism in ...
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (Nasdaq: INKT), a clinical-stage biopharmaceutical ...
Acute promyelocytic leukemia (APL) represents a paradigm of targeted therapy in hematologic malignancies. Once regarded as ...
Purpose of Study: The purpose of this study is to establish the safety and potential effectiveness of investigational FT819 in participants with moderate to severe systemic lupus erythematosus (SLE) ...
The ALBORADA Drug Discovery Institute, University of Cambridge, Cambridge, United Kingdom ...
Objective Inflammation and repair responses may be involved in atherosclerosis in rheumatoid arthritis (RA), although ...
Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...
The transcription factor NF-κB is a key regulator of cell fate, extensively involved in various physiological and pathological processes such as ...
Professor Alexander Hoffmann and Genhong Cheng from University of California, Los Angeles, jointly with Professor David ...
Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback